SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    X. Baraliakos, J. Listing, J. Buschmann, A. von der Recke, J. Braun, A comparison of new bone formation in patients with ankylosing spondylitis and patients with diffuse idiopathic skeletal hyperostosis: A retrospective cohort study over six years, Arthritis & Rheumatism, 2012, 64, 4
  2. 2
    Zaiying Hu, Manlong Xu, Qiuxia Li, Zhiming Lin, Zetao Liao, Shuangyan Cao, Qiujing Wei, Yan li Zhang, Tianwang Li, Ou Jin, Jianlin Huang, Yunfeng Pan, Yuqiong Wu, Xinghe Deng, Jieruo Gu, Adalimumab significantly reduces inflammation and serum DKK-1 level but increases fatty deposition in lumbar spine in active ankylosing spondylitis, International Journal of Rheumatic Diseases, 2012, 15, 2
  3. 3
    Stefan TG Bruijnen, Mignon AC van der Weijden, Joannes P Klein, Otto S Hoekstra, Ronald Boellaard, J Christiaan van Denderen, Ben AC Dijkmans, Alexandre E Voskuyl, Irene E van der Horst-Bruinsma, Conny J van der Laken, Bone formation rather than inflammation reflects Ankylosing Spondylitis activity on PET-CT: a pilot study, Arthritis Research & Therapy, 2012, 14, 2, R71

    CrossRef

  4. 4
    Joachim Sieper, Developments in therapies for spondyloarthritis, Nature Reviews Rheumatology, 2012, 8, 5, 280

    CrossRef

  5. 5
    Astrid van Tubergen, Ulrich Weber, Diagnosis and classification in spondyloarthritis: identifying a chameleon, Nature Reviews Rheumatology, 2012, 8, 5, 253

    CrossRef

  6. 6
    I.H. Song, J. Sieper, Frühtherapie bei axialer Spondyloarthritis und Relevanz der radiologischen Progression, Zeitschrift für Rheumatologie, 2012, 71, 1, 38

    CrossRef

  7. 7
    Lionel N. Metz, Rosanna Wustrack, Alberto F. Lovell, Aenor J. Sawyer, Infectious, Inflammatory, and Metabolic Diseases Affecting the Athlete's Spine, Clinics in Sports Medicine, 2012, 31, 3, 535

    CrossRef

  8. 8
    Irene E. M. Bultink, Marijn Vis, Irene E. Horst-Bruinsma, Willem F. Lems, Inflammatory Rheumatic Disorders and Bone, Current Rheumatology Reports, 2012, 14, 3, 224

    CrossRef

  9. 9
    Walter P Maksymowych, MRI and X-ray in axial spondyloarthritis: the relationship between inflammatory and structural changes, Arthritis Research & Therapy, 2012, 14, 2, 207

    CrossRef

  10. 10
    X. Baraliakos, J. Braun, MRT-Untersuchungen bei axialer und peripherer Spondyloarthritis, Zeitschrift für Rheumatologie, 2012, 71, 1, 27

    CrossRef

  11. 11
    Jesús Sanz Sanz, Papel de la RMN en el diagnóstico y evolución de las espondiloartritis, Reumatología Clínica, 2012, 8, 37

    CrossRef

  12. 12
    Nigil Haroon, Walter P. Maksymowych, Proton Rahman, Florence W. L. Tsui, Finbar D. O'Shea, Robert D. Inman, Radiographic severity of ankylosing spondylitis is associated with polymorphism of the large multifunctional peptidase 2 gene in the Spondyloarthritis Research Consortium of Canada cohort, Arthritis & Rheumatism, 2012, 64, 4
  13. 13
    Ki-Jo Kim, Ji-Young Kim, Su-Jung Park, Hosung Yoon, Chong-Hyeon Yoon, Wan-Uk Kim, Chul-Soo Cho, Serum leptin levels are associated with the presence of syndesmophytes in male patients with ankylosing spondylitis, Clinical Rheumatology, 2012,

    CrossRef

  14. 14
    Philippe Lencel, Séverine Delplace, Paul Pilet, Damien Leterme, Flore Miellot, Sophie Sourice, Axelle Caudrillier, Pierre Hardouin, Jérome Guicheux, David Magne, Cell-specific effects of TNF-α and IL-1β on alkaline phosphatase: implication for syndesmophyte formation and vascular calcification, Laboratory Investigation, 2011, 91, 10, 1434

    CrossRef

  15. 15
    Praveena Chiowchanwisawakit, Robert G. W. Lambert, Barbara Conner-Spady, Walter P. Maksymowych, Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis, Arthritis & Rheumatism, 2011, 63, 8
  16. 16
    Anne Grethe Jurik, Imaging the spine in arthritis—a pictorial review, Insights into Imaging, 2011, 2, 2, 177

    CrossRef

  17. 17
    Filippo Del Grande, John A. Carrino, Marco Zanetti, Magnetic Resonance Imaging of Spondyloarthritis, Topics in Magnetic Resonance Imaging, 2011, 22, 2, 83

    CrossRef

  18. 18
    Robert Landewé, Désirée van der Heijde, New considerations in the design of clinical trials for spondyloarthritis, Clinical Investigation, 2011, 1, 11, 1505

    CrossRef

  19. 19
    Piet Geusens, Willem F Lems, Osteoimmunology and osteoporosis, Arthritis Research & Therapy, 2011, 13, 5, 242

    CrossRef

  20. 20
    Isabelle Chary-Valckenaere, Maria-Antonietta d’Agostino, Damien Loeuille, Place de l’imagerie dans la spondylarthrite, Revue du Rhumatisme, 2011, 78, 1, 26

    CrossRef

  21. 21
    Susanne Juhl Pedersen, Inge Juul Sørensen, Robert G. W. Lambert, Kay-Geert A. Hermann, Patrick Garnero, Julia Sidenius Johansen, Ole Rintek Madsen, Annette Hansen, Michael Sejer Hansen, Gorm Thamsborg, Lis Smedegaard Andersen, Ole Majgaard, Anne Gitte Loft, Jon Erlendsson, Karsten H. Asmussen, Anne Grethe Jurik, Jakob Møller, Maria Hasselquist, Dorrit Mikkelsen, Mikkel Østergaard, Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: A study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiogenesis, and cartilage and bone turnover, Arthritis & Rheumatism, 2011, 63, 12
  22. 22
    Isabelle Chary-Valckenaere, Maria-Antonietta d’Agostino, Damien Loeuille, Role for imaging studies in ankylosing spondylitis, Joint Bone Spine, 2011, 78, 2, 138

    CrossRef

  23. 23
    Ulrich Weber, Walter P. Maksymowych, Sensitivity and Specificity of Magnetic Resonance Imaging for Axial Spondyloarthritis, The American Journal of the Medical Sciences, 2011, 341, 4, 272

    CrossRef

  24. 24
    Xenofon Baraliakos, Juergen Braun, Spondyloarthritides, Best Practice & Research Clinical Rheumatology, 2011, 25, 6, 825

    CrossRef

  25. 25
    Maxime Dougados, Dominique Baeten, Spondyloarthritis, The Lancet, 2011, 377, 9783, 2127

    CrossRef

  26. 26
    Rik Lories, The balance of tissue repair and remodeling in chronic arthritis, Nature Reviews Rheumatology, 2011, 7, 12, 700

    CrossRef

  27. 27
    Dimitrios Daoussis, Andrew P. Andonopoulos, The Emerging Role of Dickkopf-1 in Bone Biology: Is It the Main Switch Controlling Bone and Joint Remodeling?, Seminars in Arthritis and Rheumatism, 2011, 41, 2, 170

    CrossRef

  28. 28
    Ulrich Weber, Mikkel Østergaard, Robert G. W. Lambert, Walter P. Maksymowych, The impact of MRI on the clinical management of inflammatory arthritides, Skeletal Radiology, 2011, 40, 9, 1153

    CrossRef

  29. 29
    Dennis McGonagle, Michael Benjamin, Rheumatology, 2011,

    CrossRef

  30. 30
    Jordi Gratacos Masmitja, Mireia Moreno Martinez-Losa, Anti-TNF therapy in Ankylosing Spondylitis (AS). Is it possible to suspend treatment?, Reumatología Clínica (English Edition), 2010, 6, 5, 237

    CrossRef

  31. 31
    Xenofon Baraliakos, Juergen Braun, Anti-TNF-α therapy with infliximab in spondyloarthritides, Expert Review of Clinical Immunology, 2010, 6, 1, 9

    CrossRef

  32. 32
    Rik J.U. Lories, Kurt de Vlam, Frank P. Luyten, Are current available therapies disease-modifying in spondyloarthritis?, Best Practice & Research Clinical Rheumatology, 2010, 24, 5, 625

    CrossRef

  33. 33
    Walter P. Maksymowych, Biomarkers in Spondyloarthritis, Current Rheumatology Reports, 2010, 12, 5, 318

    CrossRef

  34. 34
    Georg Schett, Martin Rudwaleit, Can we stop progression of ankylosing spondylitis?, Best Practice & Research Clinical Rheumatology, 2010, 24, 3, 363

    CrossRef

  35. 35
    F. Kemta Lekpa, G. Lenczner, V. Farrenq, P. Claudepierre, Comment intégrer l’imagerie moderne dans le diagnostic précoce et le suivi de la spondylarthrite ankylosante ?, Journal de Radiologie, 2010, 91, 1, 162

    CrossRef

  36. 36
    Walter P. Maksymowych, Disease modification in ankylosing spondylitis, Nature Reviews Rheumatology, 2010, 6, 2, 75

    CrossRef

  37. 37
    Hildrun Haibel, Joachim Sieper, Editorial review: how early should ankylosing spondylitis be treated with a tumor necrosis factor-blocker?, Current Opinion in Rheumatology, 2010, 22, 4, 388

    CrossRef

  38. 38
    Dimitrios Daoussis, Stamatis-Nick C. Liossis, Elena E. Solomou, Anastasia Tsanaktsi, Konstadina Bounia, Maria Karampetsou, Georgios Yiannopoulos, Andrew P. Andonopoulos, Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis, Arthritis & Rheumatism, 2010, 62, 1
  39. 39
    A. Feydy, L. Gossec, R. Bazeli, E. Pluot, J. Rousseau, R. Campagna, H. Guerini, M. Dougados, J.-L. Drapé, IRM du rachis et des articulations sacro-iliaques dans la spondylarthrite ankylosante, Journal de Radiologie, 2010, 91, 1, 140

    CrossRef

  40. 40
    A. Feydy, L. Gossec, R. Bazeli, F. Thévenin, E. Pluot, J. Rousseau, G. Lenczner, R. Campagna, H. Guerini, A. Chevrot, M. Dougados, J.-L. Drapé, IRM et spondylarthropathie, Journal de Radiologie, 2010, 91, 9, 1057

    CrossRef

  41. 41
    Jordi Gratacos Masmitja, Mireia Moreno Martinez-Losa, La terapia anti-TNF en la espondilitis anquilosante (EA). ¿Es posible suspender el tratamiento?, Reumatología Clínica, 2010, 6, 5, 237

    CrossRef

  42. 42
    Pilar Aguado Acín, Lo que el clínico debe saber sobre los mecanismos de conexión entre la inflamación y la formación de hueso. ¿Es suficiente el bloqueo de la inflamación para prevenir la osificación?, Reumatología Clínica, 2010, 6, 28

    CrossRef

  43. 43
    Helena Marzo-Ortega, Dennis McGonagle, Alexander N Bennett, Magnetic resonance imaging in spondyloarthritis, Current Opinion in Rheumatology, 2010, 22, 4, 381

    CrossRef

  44. 44
    Mikkel Østergaard, René Panduro Poggenborg, Mette Bjørndal Axelsen, Susanne Juhl Pedersen, Magnetic resonance imaging in spondyloarthritis – how to quantify findings and measure response, Best Practice & Research Clinical Rheumatology, 2010, 24, 5, 637

    CrossRef

  45. 45
    Jordi Gratacós Masmitjà, Manejo del paciente con espondiloartritis anquilosante en remisión parcial con tratamiento biológico: ¿es posible suspender el tratamiento?, Reumatología Clínica, 2010, 6, 47

    CrossRef

  46. 46
    K.B. Madsen, A.G. Jurik, MRI grading method for active and chronic spinal changes in spondyloarthritis, Clinical Radiology, 2010, 65, 1, 6

    CrossRef

  47. 47
    Nigil Haroon, MRI in ankylosing spondylitis: To be or not to be, Indian Journal of Rheumatology, 2010, 5, 4, 185

    CrossRef

  48. 48
    Samira Rostom, Maxime Dougados, Laure Gossec, New tools for diagnosing spondyloarthropathy, Joint Bone Spine, 2010, 77, 2, 108

    CrossRef

  49. 49
    Samira Rostom, Maxime Dougados, Laure Gossec, Nouveautés pour le diagnostic de spondylarthropathie, Revue du Rhumatisme, 2010, 77, 2, 131

    CrossRef

  50. 50
    C. Roux, Osteoporosis in inflammatory joint diseases, Osteoporosis International, 2010, 22, 2, 421

    CrossRef

  51. 51
    Ai Lyn Tan, Dennis McGonagle, Psoriatic arthritis: Correlation between imaging and pathology, Joint Bone Spine, 2010, 77, 3, 206

    CrossRef

  52. 52
    Ai Lyn Tan, Dennis McGonagle, Rhumatisme psoriasique : corrélation entre radiologie et anatomopathologie, Revue du Rhumatisme, 2010, 77, 3, 246

    CrossRef

  53. 53
    A. N. Bennett, H. Marzo-Ortega, A. Rehman, P. Emery, D. McGonagle, The evidence for whole-spine MRI in the assessment of axial spondyloarthropathy, Rheumatology, 2010, 49, 3, 426

    CrossRef

  54. 54
    Heiner Appel, Gisela Ruiz-Heiland, Joachim Listing, Jochen Zwerina, Martin Herrmann, Ruediger Mueller, Hildrun Haibel, Xenofon Baraliakos, Axel Hempfing, Martin Rudwaleit, Joachim Sieper, Georg Schett, Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis, Arthritis & Rheumatism, 2009, 60, 11
  55. 55
    Karine Lanfant-Weybel, Thierry Lequerré, Olivier Vittecoq, Anti-TNF alpha dans le traitement de la polyarthrite rhumatoïde et de la spondylarthrite ankylosante, La Presse Médicale, 2009, 38, 5, 774

    CrossRef

  56. 56
    Alexandra Villa-Forte, Anticytokine therapy in non-rheumatoid arthritis indications in 2009, Current Opinion in Rheumatology, 2009, 21, 3, 251

    CrossRef

  57. 57
    Rik J.U. Lories, Frank P. Luyten, Bone morphogenetic protein signaling and arthritis, Cytokine & Growth Factor Reviews, 2009, 20, 5-6, 467

    CrossRef

  58. 58
    Joachim Sieper, Can structural damage be prevented in ankylosing spondylitis?, Current Opinion in Rheumatology, 2009, 21, 4, 335

    CrossRef

  59. 59
    Gina Lisignoli, Cristina Manferdini, Katia Codeluppi, Anna Piacentini, Francesco Grassi, Luca Cattini, Giuseppe Filardo, Andrea Facchini, CCL20/CCR6 chemokine/receptor expression in bone tissue from osteoarthritis and rheumatoid arthritis patients: Different response of osteoblasts in the two groups, Journal of Cellular Physiology, 2009, 221, 1
  60. 60
    Walter P Maksymowych, MRI in ankylosing spondylitis, Current Opinion in Rheumatology, 2009, 21, 4, 313

    CrossRef

  61. 61
    Ulrich Weber, Juerg Hodler, Rahel A. Kubik, Kaspar Rufibach, Robert G. W. Lambert, Rudolf O. Kissling, Christian W. A. Pfirrmann, Walter P. Maksymowych, Sensitivity and specificity of spinal inflammatory lesions assessed by whole-body magnetic resonance imaging in patients with ankylosing spondylitis or recent-onset inflammatory back pain, Arthritis Care & Research, 2009, 61, 7